NYR 3.39% 6.1¢ nyrada inc.

Ann: Nyrada Announces US Patent Grant for PCSK9 Inhibitor, page-9

  1. neg
    3,770 Posts.
    lightbulb Created with Sketch. 171
    Ok fair enough, but you get my drift, it's ridiculously low.

    Also take into account their TBI program.
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.